4BIO Capital

Investment thesis

London-based venture firm focused solely on the advanced therapies sector, investing in early-stage companies developing treatments in areas of high unmet need across cell and gene therapy, RNA-based therapy, targeted therapies and the microbiome. Founded 2014; FCA-authorised (No. 842764).

Sector focus